Key facts
- It has raised $1.4M; the latest was Later Stage VC in Jan 2026.
- Notable investors include Baiyun Holding.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Coolwind Bio
- ·The full record, as it builds
Funding rounds
No funding rounds for Coolwind Bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Coolwind Bio
Manufacturer and provider of experimental tools intended to serve the medical industry. The company offers research and development of various laboratory consumables in the biological and chemical fields, thereby providing clients with industry-leading standard products and solutions.
- Sector
- Healthcare
- HQ
- Guangzhou, China
- Founded
- 2018
- Employees
- 1
- Website
- gentleflowbio.com/
- Ownership
- Privately Held (backing)
Coolwind Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Coolwind Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Coolwind Bio in its N-PORT filings yet. We sweep new filings monthly.